AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. EBITDA margin (%)

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥198.9B
P/E ratio
71.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202525+48.74%
Mar 31, 202416.8+16.34%
Mar 31, 202314.4-43.80%
Mar 31, 202225.7-4.14%
Mar 31, 202126.8-16.99%
Mar 31, 202032.3+13.73%
Mar 31, 201928.4-5.62%
Mar 31, 201830.1-6.45%
Mar 31, 201732.2-5.59%
Mar 31, 201634.1+38.90%
Mar 31, 201524.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)